ValuEngine upgraded shares of U.S. Physical Therapy (NYSE:USPH) from a hold rating to a buy rating in a report released on Monday morning.
Other equities analysts have also issued reports about the stock. Cantor Fitzgerald reaffirmed a buy rating and set a $80.00 target price on shares of U.S. Physical Therapy in a report on Tuesday, January 9th. Zacks Investment Research raised shares of U.S. Physical Therapy from a hold rating to a buy rating and set a $82.00 target price for the company in a report on Saturday, January 6th. Jefferies Group set a $76.00 target price on shares of U.S. Physical Therapy and gave the company a hold rating in a report on Friday, February 23rd. Finally, Barrington Research reaffirmed a hold rating on shares of U.S. Physical Therapy in a report on Friday, March 9th. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. U.S. Physical Therapy presently has a consensus rating of Hold and an average target price of $79.40.
Shares of NYSE USPH opened at $85.10 on Monday. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.28. U.S. Physical Therapy has a 12 month low of $56.50 and a 12 month high of $87.50. The company has a market cap of $1,042.35, a price-to-earnings ratio of 40.02, a price-to-earnings-growth ratio of 3.02 and a beta of 1.08.
The business also recently declared a quarterly dividend, which will be paid on Friday, April 13th. Investors of record on Wednesday, March 21st will be issued a $0.23 dividend. This represents a $0.92 annualized dividend and a yield of 1.08%. The ex-dividend date is Tuesday, March 20th. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.20. U.S. Physical Therapy’s payout ratio is presently 44.23%.
In related news, Director Bernard A. Harris, Jr. sold 6,000 shares of the business’s stock in a transaction on Monday, March 12th. The shares were sold at an average price of $86.53, for a total value of $519,180.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Glenn Mcdowell sold 2,900 shares of the business’s stock in a transaction on Thursday, March 15th. The stock was sold at an average price of $82.55, for a total transaction of $239,395.00. The disclosure for this sale can be found here. In the last three months, insiders sold 18,643 shares of company stock valued at $1,583,645. 3.10% of the stock is owned by insiders.
A number of hedge funds and other institutional investors have recently modified their holdings of USPH. BNP Paribas Arbitrage SA increased its holdings in U.S. Physical Therapy by 57.1% in the 3rd quarter. BNP Paribas Arbitrage SA now owns 6,452 shares of the company’s stock worth $396,000 after acquiring an additional 2,346 shares in the last quarter. Municipal Employees Retirement System of Michigan increased its holdings in U.S. Physical Therapy by 59.3% in the 3rd quarter. Municipal Employees Retirement System of Michigan now owns 4,700 shares of the company’s stock worth $289,000 after acquiring an additional 1,750 shares in the last quarter. Rhumbline Advisers increased its holdings in U.S. Physical Therapy by 15.8% in the 3rd quarter. Rhumbline Advisers now owns 40,729 shares of the company’s stock worth $2,503,000 after acquiring an additional 5,570 shares in the last quarter. SG Americas Securities LLC purchased a new stake in U.S. Physical Therapy in the 3rd quarter worth $170,000. Finally, TD Asset Management Inc. increased its holdings in U.S. Physical Therapy by 8.8% in the 3rd quarter. TD Asset Management Inc. now owns 16,000 shares of the company’s stock worth $983,000 after acquiring an additional 1,300 shares in the last quarter. 96.53% of the stock is owned by institutional investors.
ILLEGAL ACTIVITY WARNING: “U.S. Physical Therapy (USPH) Upgraded by ValuEngine to “Buy”” was first published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another publication, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be viewed at https://www.tickerreport.com/banking-finance/3334960/u-s-physical-therapy-usph-upgraded-by-valuengine-to-buy.html.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.